ATF4 and atherosclerosis: More recently, it has been reported that exosome-derived miR-342 from intermittent hypoxia-exposed valvular interstitial cells inhibits the eIF2α/ATF4 signaling pathway and the osteogenic differentiation and progression of calcified aortic valve disease (CAVD) [80], an inflammatory disease with similarities to atherosclerosis.